What’s Next For Haemonetics Stock?
- Wednesday, April 21, 2021, 7:15
- Market
- Add a comment
The stock price of Haemonetics, best known for its blood and plasma supplies and services, plunged over 36% in a single trading session yesterday. This can be attributed to one of its large customers – CSL Pharma – stating that it will not renew its contract (expires in June 2022) with Haemonetics..
About the Author
admin123 has written 23545 stories on this site.
